Effective bioassays are crucial in pharmaceutical development for assessing potency and detecting neutralizing antibodies in immunogenicity studies.
Our iLite IFN FAST second-generation cells offer shorter incubation times, Renilla normalization, and an assay-ready format for a rapid and convenient workflow. These advancements streamline your processes and improve data reliability, enabling you to make informed decisions faster and more effectively.